Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up-Reference-Cited by-同舟云学术

Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up

Published:2019-05 Issue:2 Volume:153 Page:326-334
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Blok F.^ORCID,Dasgupta S.^ORCID,Dinjens W.N.M.,Roes E.M.,van Beekhuizen H.J.,Ewing-Graham P.C.^ORCID

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference36 articles.

1. L.A. Torre, F. Bray, R.L. Siegel, et al. Global cancer statistics 2012. CA Cancer J. Clin.. 65 (2015) 87–108. doi: https://doi.org/10.3322/caac.21262.

2. K.B. Kuchenbaecker, J.L. Hopper, D.R. Barnes, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317 (2017) 2402–2416. doi: https://doi.org/10.1001/jama.2017.7112.

3. Genetic/Familial High-Risk Assessment: Breast and Ovarian. NCNN Clinical Practice Guidelines in Oncology V12013;National Comprehensive Cancer Network,2013

4. . S.M. Domchek, T.M. Friebel, C.F. Singer, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 304 (2010) 967–975.

5. J.M. Piek, P.J. van Diest, R.P. Zweemer, et al. Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J. Pathol. 195 (2001) 451–456.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation;Journal of Gynecologic Oncology;2025

2. Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy;Gynecologic Oncology;2024-08

3. High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors;Journal of Clinical Oncology;2023-05-10

4. Outcome and Management of Serous Tubal Intraepithelial Carcinoma Following Opportunistic Salpingectomy: Systematic Review and Meta-Analysis;Journal of Obstetrics and Gynaecology Canada;2022-11

5. Incidence of pelvic high-grade serous carcinoma after isolated STIC diagnosis: A systematic review of the literature;Frontiers in Oncology;2022-08-31